Carbon Dioxide is a Respiratory (inhalation) Gas in the Human Prescription Drug category. It is labeled and distributed by Airgas Usa, Llc. The primary component is Carbon Dioxide.
Product ID | 11054-130_2bd56e21-5bd2-4c37-8737-7ccd429e7d58 |
NDC | 11054-130 |
Product Type | Human Prescription Drug |
Proprietary Name | Carbon Dioxide |
Generic Name | Carbon Dioxide |
Dosage Form | Gas |
Route of Administration | RESPIRATORY (INHALATION) |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA / NDA |
Application Number | NDA206025 |
Labeler Name | Airgas Usa, LLC |
Substance Name | CARBON DIOXIDE |
Active Ingredient Strength | 992 mL/L |
Pharm Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2012-01-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Marketing Category | NDA |
Application Number | NDA206025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-01-02 |
Ingredient | Strength |
---|---|
CARBON DIOXIDE | 992 mL/L |
SPL SET ID: | 21ff33df-b092-4cc6-9fe2-8e5cdc475e41 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |